Quote Spy ACOR NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.



Enter Tickers





   Acorda Therapeutics (ACOR)
 
Click the portfolio to add ACOR:
Close [X]
+ Add ACOR to Portfolio
Last Trade: 23.90 +0.25 (1.06%) @ Nov-20

3-Month Chart (Larger chart w/volume)

Close [X]

1m  3m  6m  1y  2y 
Volume: 619,604 Avg Volume: 1,895,000
Day's Range: 23.13 - 24.09 52-wk Range: 14.42 - 29.27
Open: 23.48 Market Cap: 908.4M
Previous Close: 23.65 P/E: -10.9
Bid: 23.08 x 1 Div Yield: $0.00 (0.00%)
Ask: 24.43 x 1    
Spy ACOR
To see which Pros and tickerspy members own ACOR Sign up now
Indexes
Biotechnology Stocks (-0.4%)
Additional ACOR resources



Customize Links
Latest ACOR Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

To start a new thread post a Link or Note and tag it ACOR
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Acorda Therapeutics Reports Third Quarter 2009 Financial Results
ACOR  
Linked by BusinessWire - November 03, 06:00AM from (www.businesswire.com)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the third quarter of 2009. “The  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009
ACOR  
Linked by BusinessWire - October 27, 07:00AM from (www.businesswire.com)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced today that it will host a conference call and live audio webcast to report  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Analyst upgrades, downgrades and initiations: ACOR, BHI, HAL, LAZ, SLB, TRV ...
HES  HAL  TSO  TRV  SLB  BHI  BJS  NFX  IVZ  PCG  ACOR  ATI  CBI  HST  AZ  LAZ  CPX  PBR  
Linked by BloggingStocks - October 15, 11:43AM from (www.pheedcontent.com)
Analyst upgrades:

Citigroup upgraded Schlumberger (NYSE: SLB) to Buy from Hold on valuation and the company's  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top 10 Analyst Upgrades, Downgrades, Initiations
IP  PETD  WDC  SPWRA  ASML  ACOR  OPEN  TRW  LAZ  PBR  
Linked by 24/7 Wall St. - October 15, 08:27AM from (feedproxy.google.com)
These are this morning's top 10 pre-market analyst upgrades, downgrades, and initiations which we have seen early from Wall Street research firms:
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top Day Trader Alerts
SVNT  SPPI  AVNR  ACOR  TSM  INFY  
Linked by 24/7 Wall St. - October 09, 08:57AM from (feedproxy.google.com)
These are this Friday morning's top day trader and active trader alert stocks. We have provided a link through to VSInvestor.com  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Acorda Therapeutics Announces Posting of Briefing Documents for October 14 FDA Advisory Committee Meeting on Fampridine-SR
ACOR  
Linked by BusinessWire - October 09, 08:30AM from (www.businesswire.com)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has posted on its  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top Analyst Upgrades
CVS  CCE  CREE  ACOR  SVVS  ICE  
Linked by 24/7 Wall St. - August 05, 07:57AM from (feedproxy.google.com)
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Wednesday morning:
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development
ACOR  
Linked by BusinessWire - August 05, 07:00AM from (www.businesswire.com)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ruhi Khan has been named Vice President, Business Development,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Acorda Therapeutics Reports Second Quarter 2009 Financial Results
ACOR  
Linked by BusinessWire - August 04, 06:00AM from (www.businesswire.com)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the second quarter of 2009.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6


 



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource